Inspire Medical Systems, Inc. Announces FDA Approval for Apnea Hypopnea Index Indication Expansion and Increased Body Mass Index LabelingGlobeNewsWire • 06/09/23
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2023 Medtech Innovation Spotlight SeriesGlobeNewsWire • 05/16/23
UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023GlobeNewsWire • 05/03/23
Inspire Medical Systems, Inc. Announces First Quarter 2023 Financial Results and Updates 2023 OutlookGlobeNewsWire • 05/02/23
Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023GlobeNewsWire • 04/26/23
Don't Sleep On This Growth Stock: Soaring Sales Make Up For Inspire's LossesInvestors Business Daily • 04/24/23
Inspire Medical Systems, Inc. to Report First Quarter 2023 Financial Results on May 2, 2023GlobeNewsWire • 04/04/23
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumGlobeNewsWire • 03/07/23
Glancy Prongay & Murray LLP Announces Investigation of Inspire Medical Systems, Inc. (INSP)Business Wire • 02/09/23
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 GuidanceGlobeNewsWire • 02/07/23
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseZacks Investment Research • 01/31/23